Tech Company M&A Transactions
Vicept Therapeutics Acquisition
On 7/19/2011, Vicept Therapeutics was acquired by Allergan Plc. Allergan Plc said the transaction price was $275 million.
Transaction Overview
Company Name
Acquired By
Announced On
7/19/2011
Transaction Type
M&A
Amount
$275,000,000
M&A Terms
The agreement, estimated to close in the third quarter of 2011, includes a $75 million cash up-front payment by Allergan plus up to an aggregate of $200 million in payments payable by Allergan contingent upon achieving certain future development and regulatory milestones plus additional payments contingent upon acquired products achieving certain sales milestones.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
101 Lindenwood Dr. 430
Malvern, PA 19355
USA
Malvern, PA 19355
USA
Phone
Website
Email Address
Overview
icept Therapeutics Inc. is a privately held specialty biopharmaceutical company with a mission to develop the first effective topically applied therapy directed toward the erythema of rosacea and other disorders characterized by redness and or 'flushing' of the skin.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Neal Walker
Chief Financial Officer
Frank Ruffo
Chief Operating Officer
Christopher Powala
Chief Scientific Officer
Stuart Shanler
Browse more venture capital transactions:
Prev: 7/19/2011: Affectiva venture capital transaction
Next: 7/19/2011: PaperKarma venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs